Profile picture

Mr Yeshai Schary

Tel Aviv University, Tel Aviv (Israel)
Follow
Logo ESC

Contributor content

CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy
Presentation
CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources